ATE314068T1 - Behandlung von seborrhoischer dermatitis - Google Patents

Behandlung von seborrhoischer dermatitis

Info

Publication number
ATE314068T1
ATE314068T1 AT01984091T AT01984091T ATE314068T1 AT E314068 T1 ATE314068 T1 AT E314068T1 AT 01984091 T AT01984091 T AT 01984091T AT 01984091 T AT01984091 T AT 01984091T AT E314068 T1 ATE314068 T1 AT E314068T1
Authority
AT
Austria
Prior art keywords
lotion
cream
treatment
seborrhoic dermatitis
ivermectin
Prior art date
Application number
AT01984091T
Other languages
English (en)
Inventor
L Dean Parks
Original Assignee
L Dean Parks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Dean Parks filed Critical L Dean Parks
Application granted granted Critical
Publication of ATE314068T1 publication Critical patent/ATE314068T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01984091T 2000-06-29 2001-06-27 Behandlung von seborrhoischer dermatitis ATE314068T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/605,747 US6319945B1 (en) 2000-06-29 2000-06-29 Method of treatment of seborrheic dermatitis
PCT/US2001/041159 WO2002002056A2 (en) 2000-06-29 2001-06-27 Method of treatment of seborrheic dermatitis

Publications (1)

Publication Number Publication Date
ATE314068T1 true ATE314068T1 (de) 2006-01-15

Family

ID=24425042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01984091T ATE314068T1 (de) 2000-06-29 2001-06-27 Behandlung von seborrhoischer dermatitis

Country Status (10)

Country Link
US (2) US6319945B1 (de)
EP (1) EP1294375B1 (de)
JP (1) JP3802485B2 (de)
CN (1) CN1171588C (de)
AT (1) ATE314068T1 (de)
AU (1) AU2002216748A1 (de)
CA (1) CA2384448C (de)
DE (1) DE60116302T2 (de)
ES (1) ES2252312T3 (de)
WO (1) WO2002002056A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
ES2305371T3 (es) 2002-06-26 2008-11-01 Avery Dennison Corporation Peliculas polimericas orientadas en la direccion de mecanizado.
RU2350333C3 (ru) * 2003-04-24 2018-08-24 Галдерма С.А. Применение ивермектина для лечения дерматологических расстройств
FR2854074B1 (fr) * 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
EP2049333B1 (de) 2006-06-14 2012-12-05 Avery Dennison Corporation Konforme und stanzbare maschinenausgerichtete etikettenrollen und etiketten sowie herstellungsverfahren
CN101484315B (zh) 2006-06-20 2013-04-10 艾利丹尼森公司 用于热熔粘合剂标记和标签原料以及此种标签的多层聚合膜
US8791153B2 (en) * 2006-10-12 2014-07-29 Sanofi-Topaz, Inc. Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US8901163B2 (en) 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
EP2629770B1 (de) 2010-10-20 2016-05-25 Galderma S.A. Ivermectin zur behandlung von gehörgangsentzündungen
EP2629772B1 (de) 2010-10-20 2016-05-18 Galderma S.A. Ivermectin zur behandlung von hämorrhoiden
US9233118B2 (en) 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US11459488B2 (en) 2014-06-02 2022-10-04 Avery Dennison Corporation Films with enhanced scuff resistance, clarity, and conformability
CN110604741A (zh) * 2018-06-15 2019-12-24 瑞恩生化科技有限公司 抑制皮肤细胞增生的组合物及其应用
EP4062907A1 (de) 2021-03-23 2022-09-28 Substipharm Orale formulierung von ivermectin und verwendungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5877295A (en) * 1992-09-30 1999-03-02 The Center For Blood Research Antibodies which bind a subpopulation of Mac-1 (CD11b/CD18) molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
DE4328689A1 (de) * 1993-08-26 1995-03-02 Beiersdorf Ag Verfahren zur Detektion und Zählung von Mikroorganismen
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
EP0908181B8 (de) * 1996-05-20 2009-04-15 Otsuka Pharmaceutical Co., Ltd. Heilmittel fuer rosazea
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
KR100315465B1 (ko) * 1998-11-23 2002-02-19 성재갑 수용성고분자와알코올을포함하는주사제용동물구충제조성물

Also Published As

Publication number Publication date
CN1383379A (zh) 2002-12-04
WO2002002056A3 (en) 2002-03-28
CA2384448C (en) 2008-09-16
JP3802485B2 (ja) 2006-07-26
CN1171588C (zh) 2004-10-20
ES2252312T3 (es) 2006-05-16
EP1294375B1 (de) 2005-12-28
DE60116302D1 (de) 2006-02-02
CA2384448A1 (en) 2002-01-10
EP1294375A4 (de) 2004-06-09
DE60116302T2 (de) 2006-08-10
US6433006B2 (en) 2002-08-13
AU2002216748A1 (en) 2002-01-14
JP2004501939A (ja) 2004-01-22
US6319945B1 (en) 2001-11-20
EP1294375A2 (de) 2003-03-26
WO2002002056A2 (en) 2002-01-10
US20020019354A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
ATE184794T1 (de) Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
SE8804570D0 (sv) New ciclosporin crystal form process for its produktion pharmaceutical compositions containing it and its use
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
SE9603725D0 (sv) New teatment
NO962655L (no) Deutrerte virkestoffer i transdermal applikasjon
AU1870097A (en) Use of a medicament and use of mixture of substances to produce a medicament
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
NO955084L (no) Estrensteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
KR880004810A (ko) 소화성 궤양 치료제
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ZA969351B (en) Organic compositions
ATE271896T1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
DE69430867D1 (de) Verwendung von terbinafin zur behandlung von pneumocystosis
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
KR900017599A (ko) 종양 치료용 약학 조성물
DE69906091D1 (de) Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis
葛通远 et al. AN APPROACH TO THE MECHANISMS OF LASER ACUPUNCTURE IN TREATMENT OF EXOPHTHALMIC HYPERTHYROIDISM

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties